Delivery Order SPE2DB24D2205-SPE2DB24FEABK

Award Date 9/17/24
Potential Completion Date 9/18/24
Potential Value $1.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of the parent company AmerisourceBergen Corporation. The contract is for the supply of 4,564,184,989 units of the pharmaceutical product DEXMETHYLPHENIDATE ER 20 MG CP 100S. The award has a ceiling value of $4,381.42 and a period of performance through April 8, 2024. This delivery order is issued under an indefinite delivery contract (IDC) held by...
The U.S. government's Defense Logistics Agency (DLA) awarded a $1,046.82 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of 4,561,655,726 units of the prescription drug Dexmethylphenidate ER 10 mg capsules. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,156.16 firm-fixed-price delivery order is for the supply of 4567603444 DEXMETHYLPHENIDATE ER 10 MG CP 100S, a generic pharmaceutical product. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. government has awarded a delivery order contract to AmerisourceBergen Drug Corporation for the supply of 4,565,984,567 dexmethylphenidate HCL ER CP 20mg. The $1,873.52 firm fixed price contract has an ultimate completion date of October 2, 2024 and was awarded on October 1, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical. This award is part of AmerisourceBergen's Indefinite Delivery Contract with the DLA valued at up to $999,999,999 through December 2025 for...
This federal contract award, valued at $1,064.37, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The award is for the delivery of 4,568,118,743 units of DEXMETHYLPHENIDATE ER 15 MG CP, a prescription medication, with a completion date of May 5, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,439.23, is for the delivery of 4,567,748,344 units of Dexmethylphenidate ER 25 mg capsules. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and...
This federal contract award, valued at $1,161.88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,167,060 units of the prescription medication DEXMETHYLPHENIDATE ER 20 MG CP, with a performance period through May 7, 2025. This is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. Amerisourcebergen Drug...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,827.24 Firm Fixed Price Delivery Order covers the supply of 4567612809 - DEXMETHYLPHENIDATE ER 10 MG CP 100S, with a completion date of March 18, 2025. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at $999,999,999 and...
This is a federal contract award by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,535.48, is a delivery order for the supply of 4567887706 DEXMETHYLPHENIDATE ER 10 MG CP 100S. The contract has an ultimate completion date of April 14, 2025 and was awarded on April 11, 2025. The contract is a Firm Fixed Price agreement, with no set-aside designation. AmerisourceBergen holds a...
This is a firm fixed price delivery order awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract provides for the delivery of 4,563,829,906 units of the pharmaceutical product DEXMETHYLPHENIDATE ER 10 MG CP, with a potential value of $6,246.51. The delivery order has a completion date of March 4, 2024. Amerisourcebergen Drug Corp, as the prime contractor, is a for-profit organization that...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB24FEABK
    Delivery Order

The U.S. Defense Logistics Agency (DLA) awarded a $1,600.16 firm fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 4565843238 - DEXMETHYLPHENIDATE ER 10 MG CP 100S. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 through December 2025, which enables DLA Troop Support Medical to efficiently procure a comprehensive range of pharmaceutical and medical supplies to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation and the ultimate completion date is September 18, 2024.

Generated 12/17/24, 9:08 AM